Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus

(2013) Larisa Rudenko et al.   VACCINE

Memory T-Cell Immune Response in Healthy Young Adults Vaccinated with Live Attenuated Influenza A (H5N2) Vaccine

(2011) T. V. Chirkova et al.   Clinical and Vaccine Immunology

B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method

(2011) Galina Petukhova et al.   Influenza and Other Respiratory Viruses

Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries

(2011) Larisa Rudenko et al.   VACCINE

Phylogenetic Analysis of the Hemagglutinin Gene of Low Pathogenic Avian Influenza Virus H7N7 Strains in Mallards in Northern Europe

(2010) Giorgi Metreveli et al.   AVIAN DISEASES

Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials

(2010) Raburn M. Mallory et al.   PLoS One

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

(2009) Irina Kiseleva et al.   Influenza and Other Respiratory Viruses

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

(2009) Kawsar R. Talaat et al.   VACCINE

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)

(2008) Larisa Rudenko et al.   Influenza and Other Respiratory Viruses